Globe Newswire » Trang Công Nghệ | Trangcongnghe.vn

Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes

Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes

Globenewswire -

CallTower Transforms Its Global Communications Platform Through Acquisition of Momentum Telecom’s Voice and Collaboration Business

CallTower Transforms Its Global Communications Platform Through Acquisition of Momentum Telecom’s Voice and Collaboration Business

Globenewswire -

EMGA's continued success in Brazil

EMGA's continued success in Brazil

Globenewswire -

CompoSecure Opens New London Design Centre to Meet Growing International Demand for Premium Metal Cards

CompoSecure Opens New London Design Centre to Meet Growing International Demand for Premium Metal Cards

Globenewswire -

From Overseas Range Records to Zero-Carbon Factories: Chery Auto to Showcase Green Technology at 2026 Chery International User Summit

From Overseas Range Records to Zero-Carbon Factories: Chery Auto to Showcase Green Technology at 2026 Chery International User Summit

Globenewswire -

StoneX Expands FX Capabilities in Asia-Pacific with Launch of Singapore Booking Center

StoneX Expands FX Capabilities in Asia-Pacific with Launch of Singapore Booking Center

Globenewswire -

TAPI (Technology & API Services) Names Serge Rogasik CEO to lead next chapter of growth and competitiveness

TAPI (Technology & API Services) Names Serge Rogasik CEO to lead next chapter of growth and competitiveness

Globenewswire -

XEM THÊM TIN MỚI